抗脂综合征中的血管亡:病理生理学,危险因素和管理
Reine Zankar1, Reem El Jamal1, Georges El Hasbani2
1Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Clinical rheumatology
|November 19, 2025
概括
血管亡 (AVN) 是抗脂综合征 (APS) 的罕见并发症,与微血管血栓形成有关. 早期检测和干预,包括抗凝药,是控制这种骨组织死亡的关键.
科学领域:
- 类风湿病学 类风湿病学
- 血液学 血液学 血液学
- 整形外科 整形外科 整形外科
背景情况:
- 抗脂综合征 (APS) 是一种自身免疫性疾病,由于抗脂抗体导致血栓形成和怀孕问题.
- 目前APS的分类标准不包括骨科并发症,如无血管缩 (AVN).
- AVN,或缺血性骨死亡,是APS的一个未被认可的表现,通常影响部,膝盖,骨和肩膀.
研究的目的:
- 调查APS和AVN之间的关联.
- 审查AVN的病理生理学,患病率,风险因素,临床表现和APS内的管理.
主要方法:
- 使用主要医疗数据库进行了全面的文献搜索.
- 关键词包括抗脂综合征,APS,无血管缩以及相关术语.
主要成果:
- 在APS中AVN的患病率在0.9%到20%之间,归因于微血管血栓症和高凝血能力.
- 在APS中发生AVN的危险因素包括长时间使用葡萄糖皮质类药物,血小板缺血,怀孕和微血管异常.
- 早期的MRI检测和干预措施,如抗凝药,生活方式改变和手术改善了结果.
结论:
- 认识到AVN在APS中的复杂作用对于及时诊断和管理至关重要.
- 需要进一步的研究来制定预防策略,并优化与APS相关的AVN的长期治疗.
- 更好的理解和管理可以提高患者护理和APS和AVN患者的临床结果.
相关概念视频
Venous Thrombosis III: Interprofessional Care
268
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
268
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis IV: Nursing Management
188
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
188
Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
Peripheral Artery Disease I: Introduction
290
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
290
Peripheral Artery Disease III: Interprofessional Care
229
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
229


